• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 MELD 评分的肝分配时代肝移植术后死亡率的预测:多变量分析。

Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis.

机构信息

Department of General and Transplant Surgery, Ruprecht-Karls University, Heidelberg, Germany.

出版信息

PLoS One. 2014 Jun 6;9(6):e98782. doi: 10.1371/journal.pone.0098782. eCollection 2014.

DOI:10.1371/journal.pone.0098782
PMID:24905210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4048202/
Abstract

BACKGROUND AND AIMS

Liver transplantation is the only curative treatment for end-stage liver disease. While waiting list mortality can be predicted by the MELD-score, reliable scoring systems for the postoperative period do not exist. This study's objective was to identify risk factors that contribute to postoperative mortality.

METHODS

Between December 2006 and March 2011, 429 patients underwent liver transplantation in our department. Risk factors for postoperative mortality in 266 consecutive liver transplantations were identified using univariate and multivariate analyses. Patients who were <18 years, HU-listings, and split-, living related, combined or re-transplantations were excluded from the analysis. The correlation between number of risk factors and mortality was analyzed.

RESULTS

A labMELD ≥20, female sex, coronary heart disease, donor risk index >1.5 and donor Na+>145 mmol/L were identified to be independent predictive factors for postoperative mortality. With increasing number of these risk-factors, postoperative 90-day and 1-year mortality increased (0-1: 0 and 0%; 2: 2.9 and 17.4%; 3: 5.6 and 16.8%; 4: 22.2 and 33.3%; 5-6: 60.9 and 66.2%).

CONCLUSIONS

In this analysis, a simple score was derived that adequately identified patients at risk after liver transplantation. Opening a discussion on the inclusion of these parameters in the process of organ allocation may be a worthwhile venture.

摘要

背景与目的

肝移植是治疗终末期肝病的唯一根治方法。虽然 MELD 评分可以预测等待名单上的死亡率,但术后没有可靠的评分系统。本研究的目的是确定导致术后死亡的危险因素。

方法

2006 年 12 月至 2011 年 3 月,我院共进行了 429 例肝移植手术。本研究采用单因素和多因素分析,确定了 266 例连续肝移植患者术后死亡的危险因素。本研究排除了年龄<18 岁、HU 名单、劈裂、活体相关、联合或再次移植的患者。分析了风险因素的数量与死亡率之间的相关性。

结果

实验室 MELD 评分≥20、女性、冠心病、供体风险指数>1.5 和供体 Na+>145mmol/L 被确定为术后死亡的独立预测因素。随着这些危险因素数量的增加,术后 90 天和 1 年的死亡率也随之增加(0-1:0%和 0%;2:2.9%和 17.4%;3:5.6%和 16.8%;4:22.2%和 33.3%;5-6:60.9%和 66.2%)。

结论

在本分析中,得出了一个简单的评分,可以充分识别肝移植后有风险的患者。在器官分配过程中讨论纳入这些参数可能是值得的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f865/4048202/311e81be3541/pone.0098782.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f865/4048202/24711ce13843/pone.0098782.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f865/4048202/78644689877d/pone.0098782.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f865/4048202/311e81be3541/pone.0098782.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f865/4048202/24711ce13843/pone.0098782.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f865/4048202/78644689877d/pone.0098782.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f865/4048202/311e81be3541/pone.0098782.g003.jpg

相似文献

1
Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis.基于 MELD 评分的肝分配时代肝移植术后死亡率的预测:多变量分析。
PLoS One. 2014 Jun 6;9(6):e98782. doi: 10.1371/journal.pone.0098782. eCollection 2014.
2
Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.终末期肝病模型(MELD)评分在预测等待肝移植患者的死亡率或从等待名单中移除的必要性方面的局限性。
BMC Gastroenterol. 2009 Sep 25;9:72. doi: 10.1186/1471-230X-9-72.
3
Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.终末期肝病模型评分高的患者右半肝活体肝移植的生存结果。
Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):256-62. doi: 10.1016/s1499-3872(13)60042-9.
4
Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.所有状态 1A 患者都应优先于高 MELD 患者吗?极危重肝移植受者的风险分层概念。
Transplantation. 2019 Oct;103(10):2121-2129. doi: 10.1097/TP.0000000000002651.
5
Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.在肝移植中是否有更好的分配指南?一种针对终末期肝病模型时代的正义和效用的新评分。
Ann Surg. 2011 Nov;254(5):745-53; discussion 753. doi: 10.1097/SLA.0b013e3182365081.
6
LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experience.基于 LabMELD 的器官分配增加了肝移植的总费用:单中心经验。
Clin Transplant. 2011 Sep-Oct;25(5):E558-65. doi: 10.1111/j.1399-0012.2011.01483.x. Epub 2011 May 17.
7
Which score system can best predict recipient outcomes after living donor liver transplantation?哪种评分系统能够最好地预测活体肝移植受者的预后?
Transplant Proc. 2012 Mar;44(2):393-5. doi: 10.1016/j.transproceed.2012.01.064.
8
The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.发展中国家的终末期肝病模型(MELD)系统与肝移植等待名单上的死亡率:来自巴西圣保罗的经验教训。
Einstein (Sao Paulo). 2012 Jul-Sep;10(3):278-85. doi: 10.1590/s1679-45082012000300004.
9
Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.肝移植时增加终末期肝病模型评分会导致住院时间延长和整体重症监护病房费用增加。
Liver Transpl. 2010 May;16(5):668-77. doi: 10.1002/lt.22027.
10
Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.终末期胆道疾病肝移植的结局:与终末期肝病的比较研究
World J Gastroenterol. 2015 May 28;21(20):6296-303. doi: 10.3748/wjg.v21.i20.6296.

引用本文的文献

1
Ultrasound assessment of abdominal wall muscle thickness in liver transplant recipients and healthy donors: a comparative study for the assessment of sarcopenia.肝移植受者与健康供体腹壁肌肉厚度的超声评估:一项用于评估肌肉减少症的对比研究。
J Ultrason. 2025 Jun 30;25(101):20250020. doi: 10.15557/jou.2025.0020. eCollection 2025 Apr.
2
Risk Evaluation and Recipient Selection in Adult Liver Transplantation: A Mixed-Methods Survey.成人肝移植中的风险评估与受者选择:一项混合方法调查。
Can Liver J. 2024 Aug 28;7(3):352-367. doi: 10.3138/canlivj-2023-0037. eCollection 2024 Aug.
3
Comprehensive biomarker assessment for predicting severe acute kidney injury and need of kidney replacement therapy in liver transplantation patients.

本文引用的文献

1
End-stage liver disease complications.终末期肝病并发症。
Curr Opin Gastroenterol. 2013 May;29(3):257-63. doi: 10.1097/MOG.0b013e32835f43b0.
2
Quality of life after adult living donor liver transplantation: A longitudinal prospective follow-up study.成人活体肝移植后生活质量:一项纵向前瞻性随访研究。
Hepatol Res. 2013 Oct;43(10):1052-63. doi: 10.1111/hepr.12060. Epub 2013 Feb 1.
3
Echocardiography in liver transplant candidates.肝移植候选人的超声心动图检查。
用于预测肝移植患者严重急性肾损伤和需要肾脏替代治疗的综合生物标志物评估。
Ren Fail. 2024 Dec;46(2):2402076. doi: 10.1080/0886022X.2024.2402076. Epub 2024 Sep 17.
4
Impact of sex on the outcomes of deceased donor liver transplantation.性别对已故供体肝移植结局的影响。
World J Transplant. 2024 Mar 18;14(1):88133. doi: 10.5500/wjt.v14.i1.88133.
5
Invasive Fungal Infections: The Early Killer after Liver Transplantation.侵袭性真菌感染:肝移植后的早期杀手
J Fungi (Basel). 2023 Jun 12;9(6):655. doi: 10.3390/jof9060655.
6
Declined Organs for Liver Transplantation: A Right Decision or a Missed Opportunity for Patients with Hepatocellular Carcinoma?肝移植被拒绝的器官:对肝细胞癌患者来说是正确的决定还是错失的机会?
Cancers (Basel). 2023 Feb 21;15(5):1365. doi: 10.3390/cancers15051365.
7
Gender specific survival rates after deceased donor liver transplantation: A retrospective cohort.已故供体肝移植后的性别特异性生存率:一项回顾性队列研究。
Ann Med Surg (Lond). 2022 Jun 5;79:103933. doi: 10.1016/j.amsu.2022.103933. eCollection 2022 Jul.
8
Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.肝移植术后死亡率和死因分析:一项大型全国队列研究的性别差异分析。
Transpl Int. 2022 May 9;35:10263. doi: 10.3389/ti.2022.10263. eCollection 2022.
9
Association of HLA-DPA1 polymorphism with prolonged mechanical ventilation in patients undergoing liver transplantation.HLA-DPA1 多态性与肝移植患者机械通气时间延长的相关性。
Korean J Anesthesiol. 2022 Oct;75(5):397-406. doi: 10.4097/kja.22014. Epub 2022 May 3.
10
Healthy Spouses can be Considered as Living Liver Donors.健康配偶可被视为活体肝脏供体。
World J Surg. 2022 Jun;46(6):1474-1484. doi: 10.1007/s00268-022-06518-9. Epub 2022 Mar 22.
JACC Cardiovasc Imaging. 2013 Jan;6(1):105-19. doi: 10.1016/j.jcmg.2012.11.002.
4
Donor hypernatremia influences outcomes following pediatric liver transplantation.供体高钠血症影响小儿肝移植后的预后。
Eur J Pediatr Surg. 2013 Feb;23(1):8-13. doi: 10.1055/s-0032-1329703. Epub 2012 Nov 19.
5
Experience Since MELD Implementation: How Does the New System Deliver?自实施终末期肝病模型(MELD)以来的经验:新系统的效果如何?
Int J Hepatol. 2012;2012:264015. doi: 10.1155/2012/264015. Epub 2012 Oct 2.
6
Liver transplant outcome: a comparison between high and low MELD score recipients.肝移植结果:高和低终末期肝病模型(MELD)评分受者之间的比较
Einstein (Sao Paulo). 2012 Jan-Mar;10(1):57-61. doi: 10.1590/s1679-45082012000100012.
7
The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity.供体风险指数、ECD评分和D-MELD评分均无法以可接受的敏感性和特异性预测肝移植后的短期预后。
Ann Transplant. 2012 Jul-Sep;17(3):5-13. doi: 10.12659/aot.883452.
8
Biliary complications after orthotopic liver transplantation: a review of incidence and risk factors.原位肝移植术后的胆道并发症:发病率及危险因素综述
Transplant Proc. 2012 Jul-Aug;44(6):1545-9. doi: 10.1016/j.transproceed.2012.05.008.
9
GFR at initiation of dialysis and mortality in CKD: a meta-analysis.透析开始时的肾小球滤过率与慢性肾脏病患者的死亡率:一项荟萃分析。
Am J Kidney Dis. 2012 Jun;59(6):829-40. doi: 10.1053/j.ajkd.2012.01.015. Epub 2012 Apr 1.
10
The J-curve revisited: a therapeutic dilemma.重新审视 J 曲线:一个治疗困境。
Cardiol Rev. 2012 Sep-Oct;20(5):253-8. doi: 10.1097/CRD.0b013e3182564a34.